Furthermore, the clinicopathological analysis revealed that the expression level of lncRNA HAGLROS was positively correlated with lymph node metastasis (P = 0.021), distant metastasis (P = 0.002), TNM stage (P = 0.000) and ER (P = 0.038) expression of patients (Fig. 1F-I, Supplementary Table 5). Here, HAGLROS is linked to metastatic malignant neoplasm in the lymph nodes.